These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8671894)

  • 1. Effects of lipoprotein(a) on mesangial cell proliferation and viability.
    Greiber S; Krämer-Guth A; Pavenstädt H; Gutenkunst M; Schollmeyer P; Wanner C
    Nephrol Dial Transplant; 1996 May; 11(5):778-85. PubMed ID: 8671894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atherogenic lipoprotein(a) as a progression factor in glomerular diseases: studies in cultured rat mesangial cells].
    Greiber S; Gutenkunst M; Wanner C
    Immun Infekt; 1995 Apr; 23(2):50-2. PubMed ID: 7744426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
    Krämer-Guth A; Greiber S; Pavenstädt H; Quaschning T; Winkler K; Schollmeyer P; Wanner C
    Kidney Int; 1996 May; 49(5):1250-61. PubMed ID: 8731088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins.
    Mondorf UF; Piiper A; Herrero M; Olbrich HG; Bender M; Gross W; Scheuermann E; Geiger H
    Kidney Int; 1999 Apr; 55(4):1359-66. PubMed ID: 10201000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells.
    Schulze-Lohoff E; Köhler M; Fees H; Reindl N; Sterzel RB
    J Hypertens; 1993 Feb; 11(2):127-34. PubMed ID: 8385171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: role of lipoprotein (a) in renal disease.
    Morishita R; Yamamoto K; Yamada S; Matsushita H; Tomita N; Sakurabayashi I; Kaneda Y; Moriguchi A; Higaki J; Ogihara T
    Biochem Biophys Res Commun; 1998 Aug; 249(2):313-20. PubMed ID: 9712693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism.
    Neverov NI; Kaysen GA; Nuccitelli R; Weiss RH
    J Am Soc Nephrol; 1997 Aug; 8(8):1247-56. PubMed ID: 9259351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression.
    Grandaliano G; Ranieri E; Monno R; Gesualdo L; Schena F
    Exp Nephrol; 1999; 7(3):229-35. PubMed ID: 10352363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
    Mohaupt M; Schoecklmann HO; Schulze-Lohoff E; Sterzel RB
    J Hypertens; 1994 Apr; 12(4):401-8. PubMed ID: 8064164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells.
    el-Dahr SS; Dipp S; Yosipiv IV; Baricos WH
    Kidney Int; 1996 Dec; 50(6):1850-5. PubMed ID: 8943466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells.
    Simonson MS
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F805-15. PubMed ID: 7977784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Lp(a) on human mesangial cell proliferation, adhesion and migration].
    Xu K; Song HM; Wei M
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):734-6. PubMed ID: 16221338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of low density lipoprotein with rat mesangial cells.
    Wasserman J; Santiago A; Rifici V; Holthofer H; Scharschmidt L; Epstein M; Schlondorff D
    Kidney Int; 1989 May; 35(5):1168-74. PubMed ID: 2770101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells.
    Orth SR; Weinreich T; Bönisch S; Weih M; Ritz E
    Exp Nephrol; 1995; 3(1):23-33. PubMed ID: 7712140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of three mitogen-activated protein kinases on lipoprotein (a)-induced human mesangial cell proliferation.
    Song HM; Wei M; Xu K; Li XW
    Chin Med J (Engl); 2010 Jan; 123(2):216-20. PubMed ID: 20137374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
    Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
    Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.